PCN7- ECONOMIC EVALUATION OF GEMZAR AND BEST SUPPORTIVE CARE (BSC) RELATIVE TO BEST SUPPORTIVE CARE ALONE IN THE TREATMENT OF NON SMALL CELL LUNG (NSCLC) CANCER IN THE UK
Abstract
Authors
J McKendrick N Botwood M Aristides M Lees N Maniadakis W Wein D Stephenson